# Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

> **NCT06148610** · — · UNKNOWN · sponsor: **Fonds de Dotation HTC Project** · enrollment: 170 (estimated)

## Conditions studied

- Hematologic Diseases
- Bone Marrow Transplantation
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DEVICE:** NewSpringForMe digital solution

## Key facts

- **NCT ID:** NCT06148610
- **Lead sponsor:** Fonds de Dotation HTC Project
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-27
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148610, "Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06148610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*